David M. Frankford is Professor of Law at Rutgers Law School; Professor at the Rutgers Institute for Health, Health Care Policy and Aging Research in New Brunswick; Faculty Director at Camden of the Rutgers Center for State Health Policy; and Member of the Rutgers Graduate Department of Public Policy and Administration in Camden. He is also the editor of “Behind the Jargon,” a Special Section of the Journal of Health Politics, Policy and Law, having previously served as book review and associate editor.
Professor Frankford’s writings have focused on the interactions between health services research, health care politics and policy, and the institutions of professions and professionalism. His works include studies of hospital reimbursement, the regulation of fee splitting, the debates concerning privatization and national health insurance, the ideology of professionalism, the role of professionalism in medical education, the role of scientism and economism in health policy, issues of insurance coverage, and numerous other issues in health care financing. With Sara Rosenbaum, he is the author of the second edition of Law and the American Health Care System.
He has been involved in many grants to the Rutgers Center for State Health Policy, offering analysis on such topics as state pharmacy assistance programs and hospital responses to mandatory medical error reporting. He also has participated in bioethics projects at The Hastings Center and the Center for Bioethics at the University of Pennsylvania. Currently his primary research interests concern the reconstitution of professionalism as the normative integration of professions and community, and the comparison of secular and religious bioethics regarding such issues as the new genetics.
Recent Posts by David Frankford
For more than three and a half decades health care expenditures in the United States have grown at a much higher rate than those in other wealthy nations. To get a handle on prices, policymakers should seriously consider rate regulation.
Despite concerns outlined in our previous post on reference pricing, federal oversight agencies essentially have taken a hands-off approach. First, they announced that for large group and self-insured plans, the Affordable Care Act's (ACA) annual maximum limits on out-of-pocket costs do not...
Editor's note: This post is part one of two on reference pricing. The use of reference pricing by health insurers and employee health benefit plans stands high on the policy and regulatory agenda because it is gaining popularity, particularly now that federal agencies have blessed its use...